Guerbet (LTS:0ELV) Net Interest Margin (Bank Only) %


LTS:0ELV Guerbet SA LTS:0ELV
55 GF Score
Price €8.78
GF Value €19.61
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Guerbet Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0ELV
55GF Score
Guerbet SA LTS:0ELV
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guerbet (LTS:0ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Guerbet stock appears to be undervalued. The current stock price of €8.78 is trading 55.2% below its estimated GF Value™ of €19.61. GuruFocus considers Guerbet to be Possible Value Trap.

Key valuation signals for LTS:0ELV:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €19.61 vs. price of €8.78 (55.2% below fair value)
  • GF Score™: 55/100 with 5 warning signs

No single metric tells the full story. See the LTS:0ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guerbet Business Description

Other Exchanges GBT:France4G8:Germany
Address 15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
55GF Score

Get the complete analysis for LTS:0ELV

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.78
Price
€19.61
GF Value